Karo Bio amends rights offering

Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Metabolic, Endocrine Date announced: 11/22/10 Type: Rights offering To be raised: SEK325 million ($47.4 million) Shares: 232.2 million Price: SEK1.4...